Dataset statistics
| Number of variables | 27 |
|---|---|
| Number of observations | 5783 |
| Missing cells | 18804 |
| Missing cells (%) | 12.0% |
| Duplicate rows | 0 |
| Duplicate rows (%) | 0.0% |
| Total size in memory | 1.2 MiB |
| Average record size in memory | 216.0 B |
Variable types
| Numeric | 2 |
|---|---|
| Text | 13 |
| Categorical | 6 |
| DateTime | 6 |
Phases is highly overall correlated with Study Type | High correlation |
Study Type is highly overall correlated with Phases | High correlation |
Study Results is highly imbalanced (94.5%) | Imbalance |
Gender is highly imbalanced (84.3%) | Imbalance |
Funded Bys is highly imbalanced (72.7%) | Imbalance |
Study Type is highly imbalanced (67.1%) | Imbalance |
Acronym has 3303 (57.1%) missing values | Missing |
Interventions has 886 (15.3%) missing values | Missing |
Phases has 2461 (42.6%) missing values | Missing |
Results First Posted has 5747 (99.4%) missing values | Missing |
Locations has 585 (10.1%) missing values | Missing |
Study Documents has 5601 (96.9%) missing values | Missing |
Enrollment is highly skewed (γ1 = 34.06593382) | Skewed |
Rank is uniformly distributed | Uniform |
Rank has unique values | Unique |
NCT Number has unique values | Unique |
URL has unique values | Unique |
Enrollment has 107 (1.9%) zeros | Zeros |
Reproduction
| Analysis started | 2024-12-09 14:00:10.539822 |
|---|---|
| Analysis finished | 2024-12-09 14:00:18.694001 |
| Duration | 8.15 seconds |
| Software version | ydata-profiling vv4.10.0 |
| Download configuration | config.json |
Rank
Real number (ℝ)
UNIFORM  UNIQUE 
| Distinct | 5783 |
|---|---|
| Distinct (%) | 100.0% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Infinite | 0 |
| Infinite (%) | 0.0% |
| Mean | 2892 |
| Minimum | 1 |
|---|---|
| Maximum | 5783 |
| Zeros | 0 |
| Zeros (%) | 0.0% |
| Negative | 0 |
| Negative (%) | 0.0% |
| Memory size | 45.3 KiB |
Quantile statistics
| Minimum | 1 |
|---|---|
| 5-th percentile | 290.1 |
| Q1 | 1446.5 |
| median | 2892 |
| Q3 | 4337.5 |
| 95-th percentile | 5493.9 |
| Maximum | 5783 |
| Range | 5782 |
| Interquartile range (IQR) | 2891 |
Descriptive statistics
| Standard deviation | 1669.5526 |
|---|---|
| Coefficient of variation (CV) | 0.57730036 |
| Kurtosis | -1.2 |
| Mean | 2892 |
| Median Absolute Deviation (MAD) | 1446 |
| Skewness | 0 |
| Sum | 16724436 |
| Variance | 2787406 |
| Monotonicity | Strictly increasing |
| Value | Count | Frequency (%) |
| 1 | 1 | < 0.1% |
| 3864 | 1 | < 0.1% |
| 3862 | 1 | < 0.1% |
| 3861 | 1 | < 0.1% |
| 3860 | 1 | < 0.1% |
| 3859 | 1 | < 0.1% |
| 3858 | 1 | < 0.1% |
| 3857 | 1 | < 0.1% |
| 3856 | 1 | < 0.1% |
| 3855 | 1 | < 0.1% |
| Other values (5773) | 5773 |
| Value | Count | Frequency (%) |
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 1 |
| Value | Count | Frequency (%) |
| 5783 | 1 | |
| 5782 | 1 | |
| 5781 | 1 | |
| 5780 | 1 | |
| 5779 | 1 | |
| 5778 | 1 | |
| 5777 | 1 | |
| 5776 | 1 | |
| 5775 | 1 | |
| 5774 | 1 |
NCT Number
Text
UNIQUE 
| Distinct | 5783 |
|---|---|
| Distinct (%) | 100.0% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 45.3 KiB |
Length
| Max length | 11 |
|---|---|
| Median length | 11 |
| Mean length | 11 |
| Min length | 11 |
Characters and Unicode
| Total characters | 63613 |
|---|---|
| Distinct characters | 13 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 5783 ? |
|---|---|
| Unique (%) | 100.0% |
Sample
| 1st row | NCT04785898 |
|---|---|
| 2nd row | NCT04595136 |
| 3rd row | NCT04395482 |
| 4th row | NCT04416061 |
| 5th row | NCT04395924 |
| Value | Count | Frequency (%) |
| nct04785898 | 1 | < 0.1% |
| nct04473170 | 1 | < 0.1% |
| nct04416061 | 1 | < 0.1% |
| nct04395924 | 1 | < 0.1% |
| nct04516954 | 1 | < 0.1% |
| nct04476940 | 1 | < 0.1% |
| nct04634214 | 1 | < 0.1% |
| nct04602884 | 1 | < 0.1% |
| nct04384588 | 1 | < 0.1% |
| nct04355897 | 1 | < 0.1% |
| Other values (5773) | 5773 |
Most occurring characters
| Value | Count | Frequency (%) |
| 4 | 10040 | |
| 0 | 8659 | |
| N | 5783 | |
| C | 5783 | |
| T | 5783 | |
| 3 | 4654 | |
| 5 | 3741 | 5.9% |
| 6 | 3687 | 5.8% |
| 7 | 3569 | 5.6% |
| 8 | 3245 | 5.1% |
| Other values (3) | 8669 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 63613 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| 4 | 10040 | |
| 0 | 8659 | |
| N | 5783 | |
| C | 5783 | |
| T | 5783 | |
| 3 | 4654 | |
| 5 | 3741 | 5.9% |
| 6 | 3687 | 5.8% |
| 7 | 3569 | 5.6% |
| 8 | 3245 | 5.1% |
| Other values (3) | 8669 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 63613 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| 4 | 10040 | |
| 0 | 8659 | |
| N | 5783 | |
| C | 5783 | |
| T | 5783 | |
| 3 | 4654 | |
| 5 | 3741 | 5.9% |
| 6 | 3687 | 5.8% |
| 7 | 3569 | 5.6% |
| 8 | 3245 | 5.1% |
| Other values (3) | 8669 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 63613 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| 4 | 10040 | |
| 0 | 8659 | |
| N | 5783 | |
| C | 5783 | |
| T | 5783 | |
| 3 | 4654 | |
| 5 | 3741 | 5.9% |
| 6 | 3687 | 5.8% |
| 7 | 3569 | 5.6% |
| 8 | 3245 | 5.1% |
| Other values (3) | 8669 |
Title
Text
| Distinct | 5775 |
|---|---|
| Distinct (%) | 99.9% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 45.3 KiB |
Length
| Max length | 286 |
|---|---|
| Median length | 183 |
| Mean length | 80.203701 |
| Min length | 18 |
Characters and Unicode
| Total characters | 463818 |
|---|---|
| Distinct characters | 113 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 5767 ? |
|---|---|
| Unique (%) | 99.7% |
Sample
| 1st row | Diagnostic Performance of the ID Nowâ„¢ COVID-19 Screening Test Versus Simplexaâ„¢ COVID-19 Direct Assay |
|---|---|
| 2nd row | Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient |
| 3rd row | Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury |
| 4th row | The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic |
| 5th row | Maternal-foetal Transmission of SARS-Cov-2 |
| Value | Count | Frequency (%) |
| covid-19 | 4427 | 7.0% |
| of | 4038 | 6.4% |
| in | 3162 | 5.0% |
| and | 2184 | 3.5% |
| the | 1841 | 2.9% |
| patients | 1628 | 2.6% |
| with | 1480 | 2.4% |
| for | 1333 | 2.1% |
| to | 999 | 1.6% |
| study | 942 | 1.5% |
| Other values (7256) | 40908 |
Most occurring characters
| Value | Count | Frequency (%) |
| 57159 | 12.3% | |
| e | 33925 | 7.3% |
| i | 31441 | 6.8% |
| t | 28661 | 6.2% |
| n | 28599 | 6.2% |
| a | 26418 | 5.7% |
| o | 26098 | 5.6% |
| r | 18371 | 4.0% |
| s | 16737 | 3.6% |
| l | 12504 | 2.7% |
| Other values (103) | 183905 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 463818 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| 57159 | 12.3% | |
| e | 33925 | 7.3% |
| i | 31441 | 6.8% |
| t | 28661 | 6.2% |
| n | 28599 | 6.2% |
| a | 26418 | 5.7% |
| o | 26098 | 5.6% |
| r | 18371 | 4.0% |
| s | 16737 | 3.6% |
| l | 12504 | 2.7% |
| Other values (103) | 183905 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 463818 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| 57159 | 12.3% | |
| e | 33925 | 7.3% |
| i | 31441 | 6.8% |
| t | 28661 | 6.2% |
| n | 28599 | 6.2% |
| a | 26418 | 5.7% |
| o | 26098 | 5.6% |
| r | 18371 | 4.0% |
| s | 16737 | 3.6% |
| l | 12504 | 2.7% |
| Other values (103) | 183905 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 463818 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| 57159 | 12.3% | |
| e | 33925 | 7.3% |
| i | 31441 | 6.8% |
| t | 28661 | 6.2% |
| n | 28599 | 6.2% |
| a | 26418 | 5.7% |
| o | 26098 | 5.6% |
| r | 18371 | 4.0% |
| s | 16737 | 3.6% |
| l | 12504 | 2.7% |
| Other values (103) | 183905 |
Acronym
Text
MISSING 
| Distinct | 2338 |
|---|---|
| Distinct (%) | 94.3% |
| Missing | 3303 |
| Missing (%) | 57.1% |
| Memory size | 45.3 KiB |
Length
| Max length | 14 |
|---|---|
| Median length | 10 |
| Mean length | 8.3794355 |
| Min length | 2 |
Characters and Unicode
| Total characters | 20781 |
|---|---|
| Distinct characters | 81 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 2271 ? |
|---|---|
| Unique (%) | 91.6% |
Sample
| 1st row | COVID-IDNow |
|---|---|
| 2nd row | COVID-19 |
| 3rd row | TAC-COVID19 |
| 4th row | COVID-19 |
| 5th row | TMF-COVID-19 |
| Value | Count | Frequency (%) |
| covid-19 | 76 | 2.9% |
| covid | 32 | 1.2% |
| corona | 11 | 0.4% |
| covid19 | 9 | 0.3% |
| recover | 8 | 0.3% |
| protect | 7 | 0.3% |
| scope | 6 | 0.2% |
| 2 | 6 | 0.2% |
| hope | 5 | 0.2% |
| cover | 5 | 0.2% |
| Other values (2328) | 2440 |
Most occurring characters
| Value | Count | Frequency (%) |
| C | 2297 | 11.1% |
| O | 1879 | 9.0% |
| I | 1653 | 8.0% |
| V | 1252 | 6.0% |
| D | 1077 | 5.2% |
| A | 1030 | 5.0% |
| - | 1018 | 4.9% |
| E | 995 | 4.8% |
| R | 911 | 4.4% |
| S | 790 | 3.8% |
| Other values (71) | 7879 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 20781 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| C | 2297 | 11.1% |
| O | 1879 | 9.0% |
| I | 1653 | 8.0% |
| V | 1252 | 6.0% |
| D | 1077 | 5.2% |
| A | 1030 | 5.0% |
| - | 1018 | 4.9% |
| E | 995 | 4.8% |
| R | 911 | 4.4% |
| S | 790 | 3.8% |
| Other values (71) | 7879 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 20781 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| C | 2297 | 11.1% |
| O | 1879 | 9.0% |
| I | 1653 | 8.0% |
| V | 1252 | 6.0% |
| D | 1077 | 5.2% |
| A | 1030 | 5.0% |
| - | 1018 | 4.9% |
| E | 995 | 4.8% |
| R | 911 | 4.4% |
| S | 790 | 3.8% |
| Other values (71) | 7879 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 20781 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| C | 2297 | 11.1% |
| O | 1879 | 9.0% |
| I | 1653 | 8.0% |
| V | 1252 | 6.0% |
| D | 1077 | 5.2% |
| A | 1030 | 5.0% |
| - | 1018 | 4.9% |
| E | 995 | 4.8% |
| R | 911 | 4.4% |
| S | 790 | 3.8% |
| Other values (71) | 7879 |
Status
Categorical
| Distinct | 12 |
|---|---|
| Distinct (%) | 0.2% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 45.3 KiB |
| Recruiting | |
|---|---|
| Completed | |
| Not yet recruiting | |
| Active, not recruiting | |
| Enrolling by invitation | 181 |
| Other values (7) | 242 |
Length
| Max length | 25 |
|---|---|
| Median length | 23 |
| Mean length | 12.708975 |
| Min length | 9 |
Characters and Unicode
| Total characters | 73496 |
|---|---|
| Distinct characters | 32 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 1 ? |
|---|---|
| Unique (%) | < 0.1% |
Sample
| 1st row | Active, not recruiting |
|---|---|
| 2nd row | Not yet recruiting |
| 3rd row | Recruiting |
| 4th row | Active, not recruiting |
| 5th row | Recruiting |
Common Values
| Value | Count | Frequency (%) |
| Recruiting | 2805 | |
| Completed | 1025 | 17.7% |
| Not yet recruiting | 1004 | 17.4% |
| Active, not recruiting | 526 | 9.1% |
| Enrolling by invitation | 181 | 3.1% |
| Withdrawn | 107 | 1.9% |
| Terminated | 74 | 1.3% |
| Suspended | 27 | 0.5% |
| Available | 19 | 0.3% |
| No longer available | 12 | 0.2% |
| Other values (2) | 3 | 0.1% |
Length
| Value | Count | Frequency (%) |
| recruiting | 4335 | |
| not | 1531 | 16.6% |
| completed | 1025 | 11.1% |
| yet | 1004 | 10.9% |
| active | 526 | 5.7% |
| enrolling | 181 | 2.0% |
| by | 181 | 2.0% |
| invitation | 181 | 2.0% |
| withdrawn | 107 | 1.2% |
| terminated | 74 | 0.8% |
| Other values (8) | 90 | 1.0% |
Most occurring characters
| Value | Count | Frequency (%) |
| i | 10136 | |
| t | 8966 | |
| e | 8166 | |
| r | 6247 | |
| n | 5808 | |
| c | 4861 | 6.6% |
| g | 4530 | 6.2% |
| u | 4362 | 5.9% |
| 3452 | 4.7% | |
| o | 2947 | 4.0% |
| Other values (22) | 14021 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 73496 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| i | 10136 | |
| t | 8966 | |
| e | 8166 | |
| r | 6247 | |
| n | 5808 | |
| c | 4861 | 6.6% |
| g | 4530 | 6.2% |
| u | 4362 | 5.9% |
| 3452 | 4.7% | |
| o | 2947 | 4.0% |
| Other values (22) | 14021 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 73496 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| i | 10136 | |
| t | 8966 | |
| e | 8166 | |
| r | 6247 | |
| n | 5808 | |
| c | 4861 | 6.6% |
| g | 4530 | 6.2% |
| u | 4362 | 5.9% |
| 3452 | 4.7% | |
| o | 2947 | 4.0% |
| Other values (22) | 14021 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 73496 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| i | 10136 | |
| t | 8966 | |
| e | 8166 | |
| r | 6247 | |
| n | 5808 | |
| c | 4861 | 6.6% |
| g | 4530 | 6.2% |
| u | 4362 | 5.9% |
| 3452 | 4.7% | |
| o | 2947 | 4.0% |
| Other values (22) | 14021 |
Study Results
Categorical
IMBALANCE 
| Distinct | 2 |
|---|---|
| Distinct (%) | < 0.1% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 45.3 KiB |
| No Results Available | |
|---|---|
| Has Results | 36 |
Length
| Max length | 20 |
|---|---|
| Median length | 20 |
| Mean length | 19.943974 |
| Min length | 11 |
Characters and Unicode
| Total characters | 115336 |
|---|---|
| Distinct characters | 15 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | No Results Available |
|---|---|
| 2nd row | No Results Available |
| 3rd row | No Results Available |
| 4th row | No Results Available |
| 5th row | No Results Available |
Common Values
| Value | Count | Frequency (%) |
| No Results Available | 5747 | |
| Has Results | 36 | 0.6% |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| results | 5783 | |
| no | 5747 | |
| available | 5747 | |
| has | 36 | 0.2% |
Most occurring characters
| Value | Count | Frequency (%) |
| l | 17277 | |
| s | 11602 | |
| 11530 | ||
| e | 11530 | |
| a | 11530 | |
| R | 5783 | 5.0% |
| u | 5783 | 5.0% |
| t | 5783 | 5.0% |
| N | 5747 | 5.0% |
| o | 5747 | 5.0% |
| Other values (5) | 23024 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 115336 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| l | 17277 | |
| s | 11602 | |
| 11530 | ||
| e | 11530 | |
| a | 11530 | |
| R | 5783 | 5.0% |
| u | 5783 | 5.0% |
| t | 5783 | 5.0% |
| N | 5747 | 5.0% |
| o | 5747 | 5.0% |
| Other values (5) | 23024 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 115336 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| l | 17277 | |
| s | 11602 | |
| 11530 | ||
| e | 11530 | |
| a | 11530 | |
| R | 5783 | 5.0% |
| u | 5783 | 5.0% |
| t | 5783 | 5.0% |
| N | 5747 | 5.0% |
| o | 5747 | 5.0% |
| Other values (5) | 23024 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 115336 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| l | 17277 | |
| s | 11602 | |
| 11530 | ||
| e | 11530 | |
| a | 11530 | |
| R | 5783 | 5.0% |
| u | 5783 | 5.0% |
| t | 5783 | 5.0% |
| N | 5747 | 5.0% |
| o | 5747 | 5.0% |
| Other values (5) | 23024 |
Conditions
Text
| Distinct | 3067 |
|---|---|
| Distinct (%) | 53.0% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 45.3 KiB |
Length
| Max length | 604 |
|---|---|
| Median length | 288 |
| Mean length | 30.595193 |
| Min length | 3 |
Characters and Unicode
| Total characters | 176932 |
|---|---|
| Distinct characters | 79 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 2766 ? |
|---|---|
| Unique (%) | 47.8% |
Sample
| 1st row | Covid19 |
|---|---|
| 2nd row | SARS-CoV-2 Infection |
| 3rd row | covid19 |
| 4th row | COVID |
| 5th row | Maternal Fetal Infection Transmission|COVID-19|SARS-CoV 2 |
| Value | Count | Frequency (%) |
| covid-19 | 1166 | 7.4% |
| covid19 | 753 | 4.8% |
| infection | 495 | 3.2% |
| respiratory | 390 | 2.5% |
| coronavirus | 357 | 2.3% |
| virus | 245 | 1.6% |
| acute | 241 | 1.5% |
| syndrome | 221 | 1.4% |
| disease | 220 | 1.4% |
| covid | 201 | 1.3% |
| Other values (4600) | 11393 |
Most occurring characters
| Value | Count | Frequency (%) |
| i | 12718 | 7.2% |
| e | 12549 | 7.1% |
| o | 12066 | 6.8% |
| 9899 | 5.6% | |
| n | 9595 | 5.4% |
| r | 9056 | 5.1% |
| a | 8799 | 5.0% |
| s | 8136 | 4.6% |
| t | 7823 | 4.4% |
| C | 6927 | 3.9% |
| Other values (69) | 79364 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 176932 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| i | 12718 | 7.2% |
| e | 12549 | 7.1% |
| o | 12066 | 6.8% |
| 9899 | 5.6% | |
| n | 9595 | 5.4% |
| r | 9056 | 5.1% |
| a | 8799 | 5.0% |
| s | 8136 | 4.6% |
| t | 7823 | 4.4% |
| C | 6927 | 3.9% |
| Other values (69) | 79364 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 176932 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| i | 12718 | 7.2% |
| e | 12549 | 7.1% |
| o | 12066 | 6.8% |
| 9899 | 5.6% | |
| n | 9595 | 5.4% |
| r | 9056 | 5.1% |
| a | 8799 | 5.0% |
| s | 8136 | 4.6% |
| t | 7823 | 4.4% |
| C | 6927 | 3.9% |
| Other values (69) | 79364 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 176932 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| i | 12718 | 7.2% |
| e | 12549 | 7.1% |
| o | 12066 | 6.8% |
| 9899 | 5.6% | |
| n | 9595 | 5.4% |
| r | 9056 | 5.1% |
| a | 8799 | 5.0% |
| s | 8136 | 4.6% |
| t | 7823 | 4.4% |
| C | 6927 | 3.9% |
| Other values (69) | 79364 |
Interventions
Text
MISSING 
| Distinct | 4337 |
|---|---|
| Distinct (%) | 88.6% |
| Missing | 886 |
| Missing (%) | 15.3% |
| Memory size | 45.3 KiB |
Length
| Max length | 1279 |
|---|---|
| Median length | 336 |
| Mean length | 55.768838 |
| Min length | 9 |
Characters and Unicode
| Total characters | 273100 |
|---|---|
| Distinct characters | 111 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 4076 ? |
|---|---|
| Unique (%) | 83.2% |
Sample
| 1st row | Diagnostic Test: ID Nowâ„¢ COVID-19 Screening Test |
|---|---|
| 2nd row | Drug: Drug COVID19-0001-USR|Drug: normal saline |
| 3rd row | Other: Lung CT scan analysis in COVID-19 patients |
| 4th row | Diagnostic Test: COVID 19 Diagnostic Test |
| 5th row | Diagnostic Test: Diagnosis of SARS-Cov2 by RT-PCR and : IgG, Ig M serologies in the amniotoc fluid, the blood cord and the placenta |
| Value | Count | Frequency (%) |
| drug | 1547 | 5.0% |
| other | 1179 | 3.8% |
| test | 836 | 2.7% |
| placebo | 798 | 2.6% |
| biological | 635 | 2.1% |
| of | 573 | 1.9% |
| diagnostic | 532 | 1.7% |
| behavioral | 513 | 1.7% |
| and | 402 | 1.3% |
| device | 338 | 1.1% |
| Other values (6737) | 23417 |
Most occurring characters
| Value | Count | Frequency (%) |
| 25873 | 9.5% | |
| e | 21134 | 7.7% |
| i | 18148 | 6.6% |
| a | 17284 | 6.3% |
| o | 16654 | 6.1% |
| r | 15540 | 5.7% |
| t | 14734 | 5.4% |
| n | 13009 | 4.8% |
| l | 11043 | 4.0% |
| s | 9097 | 3.3% |
| Other values (101) | 110584 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 273100 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| 25873 | 9.5% | |
| e | 21134 | 7.7% |
| i | 18148 | 6.6% |
| a | 17284 | 6.3% |
| o | 16654 | 6.1% |
| r | 15540 | 5.7% |
| t | 14734 | 5.4% |
| n | 13009 | 4.8% |
| l | 11043 | 4.0% |
| s | 9097 | 3.3% |
| Other values (101) | 110584 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 273100 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| 25873 | 9.5% | |
| e | 21134 | 7.7% |
| i | 18148 | 6.6% |
| a | 17284 | 6.3% |
| o | 16654 | 6.1% |
| r | 15540 | 5.7% |
| t | 14734 | 5.4% |
| n | 13009 | 4.8% |
| l | 11043 | 4.0% |
| s | 9097 | 3.3% |
| Other values (101) | 110584 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 273100 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| 25873 | 9.5% | |
| e | 21134 | 7.7% |
| i | 18148 | 6.6% |
| a | 17284 | 6.3% |
| o | 16654 | 6.1% |
| r | 15540 | 5.7% |
| t | 14734 | 5.4% |
| n | 13009 | 4.8% |
| l | 11043 | 4.0% |
| s | 9097 | 3.3% |
| Other values (101) | 110584 |
Outcome Measures
Text
| Distinct | 5687 |
|---|---|
| Distinct (%) | 98.9% |
| Missing | 35 |
| Missing (%) | 0.6% |
| Memory size | 45.3 KiB |
Length
| Max length | 11709 |
|---|---|
| Median length | 1385 |
| Mean length | 369.49304 |
| Min length | 3 |
Characters and Unicode
| Total characters | 2123846 |
|---|---|
| Distinct characters | 145 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 5637 ? |
|---|---|
| Unique (%) | 98.1% |
Sample
| 1st row | Evaluate the diagnostic performance of the ID Now â„¢ COVID-19 test carried out by nurses in an emergency department in comparison with the reference PCR test: Simplexa â„¢ COVID-19 Direct |
|---|---|
| 2nd row | Change on viral load results from baseline after using COVID19-0001-USR via nebulization |
| 3rd row | A qualitative analysis of parenchymal lung damage induced by COVID-19|A quantitative analysis of parenchymal lung damage induced by COVID-19|The potential impact of parenchymal morphological CT scans in patients with severe moderate respiratory failure.|Automated segmentation of lung scans of patients with COVID-19 and ARDS.|Knowledge of chest CT features in COVID-19 patients and their detail through the use of machine learning and other quantitative techniques.|The ability within which the analysis of artificial intelligence that uses deep learning models can be used to predict clinical outcomes |
| 4th row | Proportion of asymptomatic subjects|Proportion of subjects with recent contact history|Proportion of subjects with recent travel history |
| 5th row | COVID-19 by positive PCR in cord blood and / or positive serologies|COVID-19 by positive PCR in amniotic fluid and placenta|New born infected by COVID-19 |
| Value | Count | Frequency (%) |
| of | 21816 | 8.2% |
| in | 8367 | 3.1% |
| the | 7507 | 2.8% |
| and | 5884 | 2.2% |
| to | 5032 | 1.9% |
| with | 3481 | 1.3% |
| covid-19 | 2558 | 1.0% |
| from | 2527 | 0.9% |
| at | 2503 | 0.9% |
| by | 2215 | 0.8% |
| Other values (32481) | 204515 |
Most occurring characters
| Value | Count | Frequency (%) |
| 260657 | 12.3% | |
| e | 189729 | 8.9% |
| i | 145165 | 6.8% |
| t | 141306 | 6.7% |
| a | 137378 | 6.5% |
| o | 131711 | 6.2% |
| n | 130531 | 6.1% |
| s | 102395 | 4.8% |
| r | 101829 | 4.8% |
| l | 63975 | 3.0% |
| Other values (135) | 719170 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 2123846 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| 260657 | 12.3% | |
| e | 189729 | 8.9% |
| i | 145165 | 6.8% |
| t | 141306 | 6.7% |
| a | 137378 | 6.5% |
| o | 131711 | 6.2% |
| n | 130531 | 6.1% |
| s | 102395 | 4.8% |
| r | 101829 | 4.8% |
| l | 63975 | 3.0% |
| Other values (135) | 719170 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 2123846 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| 260657 | 12.3% | |
| e | 189729 | 8.9% |
| i | 145165 | 6.8% |
| t | 141306 | 6.7% |
| a | 137378 | 6.5% |
| o | 131711 | 6.2% |
| n | 130531 | 6.1% |
| s | 102395 | 4.8% |
| r | 101829 | 4.8% |
| l | 63975 | 3.0% |
| Other values (135) | 719170 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 2123846 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| 260657 | 12.3% | |
| e | 189729 | 8.9% |
| i | 145165 | 6.8% |
| t | 141306 | 6.7% |
| a | 137378 | 6.5% |
| o | 131711 | 6.2% |
| n | 130531 | 6.1% |
| s | 102395 | 4.8% |
| r | 101829 | 4.8% |
| l | 63975 | 3.0% |
| Other values (135) | 719170 |
| Distinct | 3631 |
|---|---|
| Distinct (%) | 62.8% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 45.3 KiB |
Length
| Max length | 3268 |
|---|---|
| Median length | 588 |
| Mean length | 61.998962 |
| Min length | 5 |
Characters and Unicode
| Total characters | 358540 |
|---|---|
| Distinct characters | 135 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 2937 ? |
|---|---|
| Unique (%) | 50.8% |
Sample
| 1st row | Groupe Hospitalier Paris Saint Joseph |
|---|---|
| 2nd row | United Medical Specialties |
| 3rd row | University of Milano Bicocca |
| 4th row | Hong Kong Sanatorium & Hospital |
| 5th row | Centre Hospitalier Régional d'Orléans|Centre de Biophysique Moléculaire - Pr Chantal Pichon|Professeur TOUMI Hechmi |
| Value | Count | Frequency (%) |
| university | 2520 | 6.1% |
| of | 2438 | 5.9% |
| hospital | 1441 | 3.5% |
| de | 1246 | 3.0% |
| and | 757 | 1.8% |
| medical | 667 | 1.6% |
| health | 662 | 1.6% |
| research | 634 | 1.5% |
| institute | 527 | 1.3% |
| center | 371 | 0.9% |
| Other values (9432) | 29901 |
Most occurring characters
| Value | Count | Frequency (%) |
| 35381 | 9.9% | |
| i | 30587 | 8.5% |
| e | 30199 | 8.4% |
| a | 26112 | 7.3% |
| n | 22908 | 6.4% |
| t | 21619 | 6.0% |
| o | 18857 | 5.3% |
| r | 18208 | 5.1% |
| s | 17607 | 4.9% |
| l | 14264 | 4.0% |
| Other values (125) | 122798 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 358540 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| 35381 | 9.9% | |
| i | 30587 | 8.5% |
| e | 30199 | 8.4% |
| a | 26112 | 7.3% |
| n | 22908 | 6.4% |
| t | 21619 | 6.0% |
| o | 18857 | 5.3% |
| r | 18208 | 5.1% |
| s | 17607 | 4.9% |
| l | 14264 | 4.0% |
| Other values (125) | 122798 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 358540 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| 35381 | 9.9% | |
| i | 30587 | 8.5% |
| e | 30199 | 8.4% |
| a | 26112 | 7.3% |
| n | 22908 | 6.4% |
| t | 21619 | 6.0% |
| o | 18857 | 5.3% |
| r | 18208 | 5.1% |
| s | 17607 | 4.9% |
| l | 14264 | 4.0% |
| Other values (125) | 122798 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 358540 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| 35381 | 9.9% | |
| i | 30587 | 8.5% |
| e | 30199 | 8.4% |
| a | 26112 | 7.3% |
| n | 22908 | 6.4% |
| t | 21619 | 6.0% |
| o | 18857 | 5.3% |
| r | 18208 | 5.1% |
| s | 17607 | 4.9% |
| l | 14264 | 4.0% |
| Other values (125) | 122798 |
Gender
Categorical
IMBALANCE 
| Distinct | 3 |
|---|---|
| Distinct (%) | 0.1% |
| Missing | 10 |
| Missing (%) | 0.2% |
| Memory size | 45.3 KiB |
| All | |
|---|---|
| Female | 162 |
| Male | 44 |
Length
| Max length | 6 |
|---|---|
| Median length | 3 |
| Mean length | 3.0918067 |
| Min length | 3 |
Characters and Unicode
| Total characters | 17849 |
|---|---|
| Distinct characters | 7 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | All |
|---|---|
| 2nd row | All |
| 3rd row | All |
| 4th row | All |
| 5th row | Female |
Common Values
| Value | Count | Frequency (%) |
| All | 5567 | |
| Female | 162 | 2.8% |
| Male | 44 | 0.8% |
| (Missing) | 10 | 0.2% |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| all | 5567 | |
| female | 162 | 2.8% |
| male | 44 | 0.8% |
Most occurring characters
| Value | Count | Frequency (%) |
| l | 11340 | |
| A | 5567 | |
| e | 368 | 2.1% |
| a | 206 | 1.2% |
| F | 162 | 0.9% |
| m | 162 | 0.9% |
| M | 44 | 0.2% |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 17849 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| l | 11340 | |
| A | 5567 | |
| e | 368 | 2.1% |
| a | 206 | 1.2% |
| F | 162 | 0.9% |
| m | 162 | 0.9% |
| M | 44 | 0.2% |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 17849 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| l | 11340 | |
| A | 5567 | |
| e | 368 | 2.1% |
| a | 206 | 1.2% |
| F | 162 | 0.9% |
| m | 162 | 0.9% |
| M | 44 | 0.2% |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 17849 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| l | 11340 | |
| A | 5567 | |
| e | 368 | 2.1% |
| a | 206 | 1.2% |
| F | 162 | 0.9% |
| m | 162 | 0.9% |
| M | 44 | 0.2% |
Age
Text
| Distinct | 417 |
|---|---|
| Distinct (%) | 7.2% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 45.3 KiB |
Length
| Max length | 51 |
|---|---|
| Median length | 41 |
| Mean length | 39.450977 |
| Min length | 22 |
Characters and Unicode
| Total characters | 228145 |
|---|---|
| Distinct characters | 38 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 236 ? |
|---|---|
| Unique (%) | 4.1% |
Sample
| 1st row | 18 Years and older  (Adult, Older Adult) |
|---|---|
| 2nd row | 18 Years and older  (Adult, Older Adult) |
| 3rd row | 18 Years and older  (Adult, Older Adult) |
| 4th row | Child, Adult, Older Adult |
| 5th row | 18 Years to 48 Years  (Adult) |
| Value | Count | Frequency (%) |
| adult | 10848 | |
| older | 8586 | |
| years | 7070 | |
| 18 | 4329 | 10.8% |
| and | 3344 | 8.3% |
| to | 1953 | 4.9% |
| child | 1011 | 2.5% |
| 80 | 283 | 0.7% |
| 65 | 240 | 0.6% |
| 75 | 169 | 0.4% |
| Other values (96) | 2323 | 5.8% |
Most occurring characters
| Value | Count | Frequency (%) |
| 39670 | ||
| d | 23789 | 10.4% |
| l | 20445 | 9.0% |
| e | 15692 | 6.9% |
| r | 15687 | 6.9% |
| t | 12855 | 5.6% |
| u | 10937 | 4.8% |
| A | 10848 | 4.8% |
| a | 10449 | 4.6% |
| s | 7120 | 3.1% |
| Other values (28) | 60653 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 228145 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| 39670 | ||
| d | 23789 | 10.4% |
| l | 20445 | 9.0% |
| e | 15692 | 6.9% |
| r | 15687 | 6.9% |
| t | 12855 | 5.6% |
| u | 10937 | 4.8% |
| A | 10848 | 4.8% |
| a | 10449 | 4.6% |
| s | 7120 | 3.1% |
| Other values (28) | 60653 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 228145 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| 39670 | ||
| d | 23789 | 10.4% |
| l | 20445 | 9.0% |
| e | 15692 | 6.9% |
| r | 15687 | 6.9% |
| t | 12855 | 5.6% |
| u | 10937 | 4.8% |
| A | 10848 | 4.8% |
| a | 10449 | 4.6% |
| s | 7120 | 3.1% |
| Other values (28) | 60653 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 228145 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| 39670 | ||
| d | 23789 | 10.4% |
| l | 20445 | 9.0% |
| e | 15692 | 6.9% |
| r | 15687 | 6.9% |
| t | 12855 | 5.6% |
| u | 10937 | 4.8% |
| A | 10848 | 4.8% |
| a | 10449 | 4.6% |
| s | 7120 | 3.1% |
| Other values (28) | 60653 |
Phases
Categorical
HIGH CORRELATION  MISSING 
| Distinct | 8 |
|---|---|
| Distinct (%) | 0.2% |
| Missing | 2461 |
| Missing (%) | 42.6% |
| Memory size | 45.3 KiB |
| Not Applicable | |
|---|---|
| Phase 2 | |
| Phase 3 | |
| Phase 1 | |
| Phase 2|Phase 3 | |
| Other values (3) |
Length
| Max length | 15 |
|---|---|
| Median length | 14 |
| Mean length | 10.880193 |
| Min length | 7 |
Characters and Unicode
| Total characters | 36144 |
|---|---|
| Distinct characters | 23 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 0 ? |
|---|---|
| Unique (%) | 0.0% |
Sample
| 1st row | Not Applicable |
|---|---|
| 2nd row | Phase 1|Phase 2 |
| 3rd row | Early Phase 1 |
| 4th row | Not Applicable |
| 5th row | Not Applicable |
Common Values
| Value | Count | Frequency (%) |
| Not Applicable | 1354 | |
| Phase 2 | 685 | 11.8% |
| Phase 3 | 450 | 7.8% |
| Phase 1 | 234 | 4.0% |
| Phase 2|Phase 3 | 200 | 3.5% |
| Phase 1|Phase 2 | 192 | 3.3% |
| Phase 4 | 161 | 2.8% |
| Early Phase 1 | 46 | 0.8% |
| (Missing) | 2461 |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| phase | 1968 | |
| not | 1354 | |
| applicable | 1354 | |
| 2 | 877 | |
| 3 | 650 | 9.2% |
| 1 | 280 | 4.0% |
| 2|phase | 200 | 2.8% |
| 1|phase | 192 | 2.7% |
| 4 | 161 | 2.3% |
| early | 46 | 0.6% |
Most occurring characters
| Value | Count | Frequency (%) |
| 3760 | 10.4% | |
| a | 3760 | 10.4% |
| e | 3714 | 10.3% |
| l | 2754 | 7.6% |
| p | 2708 | 7.5% |
| s | 2360 | 6.5% |
| h | 2360 | 6.5% |
| P | 2360 | 6.5% |
| b | 1354 | 3.7% |
| o | 1354 | 3.7% |
| Other values (13) | 9660 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 36144 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| 3760 | 10.4% | |
| a | 3760 | 10.4% |
| e | 3714 | 10.3% |
| l | 2754 | 7.6% |
| p | 2708 | 7.5% |
| s | 2360 | 6.5% |
| h | 2360 | 6.5% |
| P | 2360 | 6.5% |
| b | 1354 | 3.7% |
| o | 1354 | 3.7% |
| Other values (13) | 9660 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 36144 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| 3760 | 10.4% | |
| a | 3760 | 10.4% |
| e | 3714 | 10.3% |
| l | 2754 | 7.6% |
| p | 2708 | 7.5% |
| s | 2360 | 6.5% |
| h | 2360 | 6.5% |
| P | 2360 | 6.5% |
| b | 1354 | 3.7% |
| o | 1354 | 3.7% |
| Other values (13) | 9660 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 36144 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| 3760 | 10.4% | |
| a | 3760 | 10.4% |
| e | 3714 | 10.3% |
| l | 2754 | 7.6% |
| p | 2708 | 7.5% |
| s | 2360 | 6.5% |
| h | 2360 | 6.5% |
| P | 2360 | 6.5% |
| b | 1354 | 3.7% |
| o | 1354 | 3.7% |
| Other values (13) | 9660 |
Enrollment
Real number (ℝ)
SKEWED  ZEROS 
| Distinct | 962 |
|---|---|
| Distinct (%) | 16.7% |
| Missing | 34 |
| Missing (%) | 0.6% |
| Infinite | 0 |
| Infinite (%) | 0.0% |
| Mean | 18319.489 |
| Minimum | 0 |
|---|---|
| Maximum | 20000000 |
| Zeros | 107 |
| Zeros (%) | 1.9% |
| Negative | 0 |
| Negative (%) | 0.0% |
| Memory size | 45.3 KiB |
Quantile statistics
| Minimum | 0 |
|---|---|
| 5-th percentile | 15 |
| Q1 | 60 |
| median | 170 |
| Q3 | 560 |
| 95-th percentile | 5315.6 |
| Maximum | 20000000 |
| Range | 20000000 |
| Interquartile range (IQR) | 500 |
Descriptive statistics
| Standard deviation | 404543.73 |
|---|---|
| Coefficient of variation (CV) | 22.082698 |
| Kurtosis | 1353.8226 |
| Mean | 18319.489 |
| Median Absolute Deviation (MAD) | 135 |
| Skewness | 34.065934 |
| Sum | 1.0531874 × 108 |
| Variance | 1.6365563 × 1011 |
| Monotonicity | Not monotonic |
| Value | Count | Frequency (%) |
| 100 | 350 | 6.1% |
| 200 | 244 | 4.2% |
| 60 | 176 | 3.0% |
| 30 | 173 | 3.0% |
| 50 | 168 | 2.9% |
| 1000 | 167 | 2.9% |
| 40 | 166 | 2.9% |
| 300 | 153 | 2.6% |
| 500 | 150 | 2.6% |
| 20 | 128 | 2.2% |
| Other values (952) | 3874 |
| Value | Count | Frequency (%) |
| 0 | 107 | |
| 1 | 8 | 0.1% |
| 2 | 8 | 0.1% |
| 3 | 4 | 0.1% |
| 4 | 5 | 0.1% |
| 5 | 18 | 0.3% |
| 6 | 5 | 0.1% |
| 7 | 6 | 0.1% |
| 8 | 9 | 0.2% |
| 9 | 9 | 0.2% |
| Value | Count | Frequency (%) |
| 20000000 | 1 | < 0.1% |
| 12000000 | 1 | < 0.1% |
| 10000000 | 2 | < 0.1% |
| 7882471 | 1 | < 0.1% |
| 7000000 | 1 | < 0.1% |
| 6000000 | 2 | < 0.1% |
| 2000000 | 1 | < 0.1% |
| 1302508 | 1 | < 0.1% |
| 1200000 | 1 | < 0.1% |
| 1000000 | 5 |
Funded Bys
Categorical
IMBALANCE 
| Distinct | 26 |
|---|---|
| Distinct (%) | 0.4% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 45.3 KiB |
| Other | |
|---|---|
| Industry | |
| Other|Industry | 216 |
| Industry|Other | 190 |
| Other|NIH | 97 |
| Other values (21) | 141 |
Length
| Max length | 27 |
|---|---|
| Median length | 5 |
| Mean length | 6.1647934 |
| Min length | 3 |
Characters and Unicode
| Total characters | 35651 |
|---|---|
| Distinct characters | 19 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 5 ? |
|---|---|
| Unique (%) | 0.1% |
Sample
| 1st row | Other |
|---|---|
| 2nd row | Other |
| 3rd row | Other |
| 4th row | Industry |
| 5th row | Other |
Common Values
| Value | Count | Frequency (%) |
| Other | 4488 | |
| Industry | 651 | 11.3% |
| Other|Industry | 216 | 3.7% |
| Industry|Other | 190 | 3.3% |
| Other|NIH | 97 | 1.7% |
| NIH | 51 | 0.9% |
| Other|U.S. Fed | 25 | 0.4% |
| U.S. Fed | 15 | 0.3% |
| Industry|U.S. Fed | 10 | 0.2% |
| NIH|Industry | 6 | 0.1% |
| Other values (16) | 34 | 0.6% |
Length
| Value | Count | Frequency (%) |
| other | 4488 | |
| industry | 651 | 11.1% |
| other|industry | 216 | 3.7% |
| industry|other | 190 | 3.2% |
| other|nih | 97 | 1.7% |
| fed | 53 | 0.9% |
| nih | 51 | 0.9% |
| other|u.s | 27 | 0.5% |
| u.s | 20 | 0.3% |
| industry|u.s | 14 | 0.2% |
| Other values (15) | 42 | 0.7% |
Most occurring characters
| Value | Count | Frequency (%) |
| t | 6141 | |
| r | 6141 | |
| e | 5113 | |
| O | 5047 | |
| h | 5047 | |
| I | 1272 | 3.6% |
| d | 1160 | 3.3% |
| y | 1094 | 3.1% |
| s | 1094 | 3.1% |
| u | 1094 | 3.1% |
| Other values (9) | 2448 | 6.9% |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 35651 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| t | 6141 | |
| r | 6141 | |
| e | 5113 | |
| O | 5047 | |
| h | 5047 | |
| I | 1272 | 3.6% |
| d | 1160 | 3.3% |
| y | 1094 | 3.1% |
| s | 1094 | 3.1% |
| u | 1094 | 3.1% |
| Other values (9) | 2448 | 6.9% |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 35651 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| t | 6141 | |
| r | 6141 | |
| e | 5113 | |
| O | 5047 | |
| h | 5047 | |
| I | 1272 | 3.6% |
| d | 1160 | 3.3% |
| y | 1094 | 3.1% |
| s | 1094 | 3.1% |
| u | 1094 | 3.1% |
| Other values (9) | 2448 | 6.9% |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 35651 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| t | 6141 | |
| r | 6141 | |
| e | 5113 | |
| O | 5047 | |
| h | 5047 | |
| I | 1272 | 3.6% |
| d | 1160 | 3.3% |
| y | 1094 | 3.1% |
| s | 1094 | 3.1% |
| u | 1094 | 3.1% |
| Other values (9) | 2448 | 6.9% |
Study Type
Categorical
HIGH CORRELATION  IMBALANCE 
| Distinct | 9 |
|---|---|
| Distinct (%) | 0.2% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 45.3 KiB |
| Interventional | |
|---|---|
| Observational | |
| Expanded Access:Intermediate-size Population | 15 |
| Expanded Access:Treatment IND/Protocol | 8 |
| Expanded Access:Intermediate-size Population|Treatment IND/Protocol | 5 |
| Other values (4) | 6 |
Length
| Max length | 67 |
|---|---|
| Median length | 14 |
| Mean length | 13.764482 |
| Min length | 13 |
Characters and Unicode
| Total characters | 79600 |
|---|---|
| Distinct characters | 31 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 3 ? |
|---|---|
| Unique (%) | 0.1% |
Sample
| 1st row | Interventional |
|---|---|
| 2nd row | Interventional |
| 3rd row | Observational |
| 4th row | Observational |
| 5th row | Observational |
Common Values
| Value | Count | Frequency (%) |
| Interventional | 3322 | |
| Observational | 2427 | |
| Expanded Access:Intermediate-size Population | 15 | 0.3% |
| Expanded Access:Treatment IND/Protocol | 8 | 0.1% |
| Expanded Access:Intermediate-size Population|Treatment IND/Protocol | 5 | 0.1% |
| Expanded Access:Individual Patients | 3 | 0.1% |
| Expanded Access:Individual Patients|Intermediate-size Population | 1 | < 0.1% |
| Expanded Access | 1 | < 0.1% |
| Expanded Access:Individual Patients|Treatment IND/Protocol | 1 | < 0.1% |
Length
Common Values (Plot)
| Value | Count | Frequency (%) |
| interventional | 3322 | |
| observational | 2427 | |
| expanded | 34 | 0.6% |
| access:intermediate-size | 20 | 0.3% |
| population | 16 | 0.3% |
| ind/protocol | 14 | 0.2% |
| access:treatment | 8 | 0.1% |
| population|treatment | 5 | 0.1% |
| access:individual | 5 | 0.1% |
| patients | 3 | 0.1% |
| Other values (3) | 3 | 0.1% |
Most occurring characters
| Value | Count | Frequency (%) |
| n | 12493 | |
| e | 9256 | |
| t | 9186 | |
| a | 8276 | |
| o | 5833 | |
| i | 5827 | |
| r | 5798 | |
| l | 5789 | |
| v | 5754 | |
| I | 3362 | 4.2% |
| Other values (21) | 8026 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 79600 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| n | 12493 | |
| e | 9256 | |
| t | 9186 | |
| a | 8276 | |
| o | 5833 | |
| i | 5827 | |
| r | 5798 | |
| l | 5789 | |
| v | 5754 | |
| I | 3362 | 4.2% |
| Other values (21) | 8026 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 79600 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| n | 12493 | |
| e | 9256 | |
| t | 9186 | |
| a | 8276 | |
| o | 5833 | |
| i | 5827 | |
| r | 5798 | |
| l | 5789 | |
| v | 5754 | |
| I | 3362 | 4.2% |
| Other values (21) | 8026 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 79600 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| n | 12493 | |
| e | 9256 | |
| t | 9186 | |
| a | 8276 | |
| o | 5833 | |
| i | 5827 | |
| r | 5798 | |
| l | 5789 | |
| v | 5754 | |
| I | 3362 | 4.2% |
| Other values (21) | 8026 |
Study Designs
Text
| Distinct | 267 |
|---|---|
| Distinct (%) | 4.6% |
| Missing | 35 |
| Missing (%) | 0.6% |
| Memory size | 45.3 KiB |
Length
| Max length | 176 |
|---|---|
| Median length | 168 |
| Mean length | 100.38309 |
| Min length | 50 |
Characters and Unicode
| Total characters | 577002 |
|---|---|
| Distinct characters | 48 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 103 ? |
|---|---|
| Unique (%) | 1.8% |
Sample
| 1st row | Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic |
|---|---|
| 2nd row | Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment |
| 3rd row | Observational Model: Cohort|Time Perspective: Retrospective |
| 4th row | Observational Model: Cohort|Time Perspective: Retrospective |
| 5th row | Observational Model: Cohort|Time Perspective: Prospective |
| Value | Count | Frequency (%) |
| model | 5748 | 11.7% |
| assignment|masking | 3322 | 6.8% |
| purpose | 3322 | 6.8% |
| allocation | 3319 | 6.8% |
| randomized|intervention | 2459 | 5.0% |
| observational | 2426 | 4.9% |
| perspective | 2426 | 4.9% |
| parallel | 2372 | 4.8% |
| treatment | 2044 | 4.2% |
| label)|primary | 1734 | 3.5% |
| Other values (46) | 19942 |
Most occurring characters
| Value | Count | Frequency (%) |
| e | 60671 | 10.5% |
| 43366 | 7.5% | |
| n | 40055 | 6.9% |
| o | 38596 | 6.7% |
| i | 36295 | 6.3% |
| r | 35705 | 6.2% |
| t | 34246 | 5.9% |
| a | 32675 | 5.7% |
| s | 27475 | 4.8% |
| l | 27150 | 4.7% |
| Other values (38) | 200768 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 577002 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| e | 60671 | 10.5% |
| 43366 | 7.5% | |
| n | 40055 | 6.9% |
| o | 38596 | 6.7% |
| i | 36295 | 6.3% |
| r | 35705 | 6.2% |
| t | 34246 | 5.9% |
| a | 32675 | 5.7% |
| s | 27475 | 4.8% |
| l | 27150 | 4.7% |
| Other values (38) | 200768 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 577002 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| e | 60671 | 10.5% |
| 43366 | 7.5% | |
| n | 40055 | 6.9% |
| o | 38596 | 6.7% |
| i | 36295 | 6.3% |
| r | 35705 | 6.2% |
| t | 34246 | 5.9% |
| a | 32675 | 5.7% |
| s | 27475 | 4.8% |
| l | 27150 | 4.7% |
| Other values (38) | 200768 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 577002 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| e | 60671 | 10.5% |
| 43366 | 7.5% | |
| n | 40055 | 6.9% |
| o | 38596 | 6.7% |
| i | 36295 | 6.3% |
| r | 35705 | 6.2% |
| t | 34246 | 5.9% |
| a | 32675 | 5.7% |
| s | 27475 | 4.8% |
| l | 27150 | 4.7% |
| Other values (38) | 200768 |
Other IDs
Text
| Distinct | 5734 |
|---|---|
| Distinct (%) | 99.2% |
| Missing | 1 |
| Missing (%) | < 0.1% |
| Memory size | 45.3 KiB |
Length
| Max length | 90 |
|---|---|
| Median length | 65 |
| Mean length | 13.310792 |
| Min length | 1 |
Characters and Unicode
| Total characters | 76963 |
|---|---|
| Distinct characters | 104 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 5701 ? |
|---|---|
| Unique (%) | 98.6% |
Sample
| 1st row | COVID-IDNow |
|---|---|
| 2nd row | COVID19-0001-USR |
| 3rd row | TAC-COVID19 |
| 4th row | RC-2020-08 |
| 5th row | CHRO-2020-10 |
| Value | Count | Frequency (%) |
| covid-19 | 120 | 1.7% |
| covid | 77 | 1.1% |
| 2020 | 52 | 0.7% |
| 46 | 0.6% | |
| in | 35 | 0.5% |
| study | 33 | 0.5% |
| 19 | 22 | 0.3% |
| covid19 | 18 | 0.2% |
| fmasu | 17 | 0.2% |
| irb | 15 | 0.2% |
| Other values (6336) | 6835 |
Most occurring characters
| Value | Count | Frequency (%) |
| 0 | 11971 | 15.6% |
| 2 | 7462 | 9.7% |
| 1 | 5340 | 6.9% |
| - | 5074 | 6.6% |
| C | 2814 | 3.7% |
| 3 | 2337 | 3.0% |
| I | 1997 | 2.6% |
| 9 | 1970 | 2.6% |
| 4 | 1779 | 2.3% |
| 5 | 1756 | 2.3% |
| Other values (94) | 34463 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 76963 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| 0 | 11971 | 15.6% |
| 2 | 7462 | 9.7% |
| 1 | 5340 | 6.9% |
| - | 5074 | 6.6% |
| C | 2814 | 3.7% |
| 3 | 2337 | 3.0% |
| I | 1997 | 2.6% |
| 9 | 1970 | 2.6% |
| 4 | 1779 | 2.3% |
| 5 | 1756 | 2.3% |
| Other values (94) | 34463 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 76963 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| 0 | 11971 | 15.6% |
| 2 | 7462 | 9.7% |
| 1 | 5340 | 6.9% |
| - | 5074 | 6.6% |
| C | 2814 | 3.7% |
| 3 | 2337 | 3.0% |
| I | 1997 | 2.6% |
| 9 | 1970 | 2.6% |
| 4 | 1779 | 2.3% |
| 5 | 1756 | 2.3% |
| Other values (94) | 34463 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 76963 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| 0 | 11971 | 15.6% |
| 2 | 7462 | 9.7% |
| 1 | 5340 | 6.9% |
| - | 5074 | 6.6% |
| C | 2814 | 3.7% |
| 3 | 2337 | 3.0% |
| I | 1997 | 2.6% |
| 9 | 1970 | 2.6% |
| 4 | 1779 | 2.3% |
| 5 | 1756 | 2.3% |
| Other values (94) | 34463 |
Start Date
Date
| Distinct | 628 |
|---|---|
| Distinct (%) | 10.9% |
| Missing | 34 |
| Missing (%) | 0.6% |
| Memory size | 45.3 KiB |
| Minimum | 1998-01-01 00:00:00 |
|---|---|
| Maximum | 2022-01-01 00:00:00 |
| Distinct | 828 |
|---|---|
| Distinct (%) | 14.4% |
| Missing | 36 |
| Missing (%) | 0.6% |
| Memory size | 45.3 KiB |
| Minimum | 2016-05-31 00:00:00 |
|---|---|
| Maximum | 2099-12-31 00:00:00 |
Completion Date
Date
| Distinct | 923 |
|---|---|
| Distinct (%) | 16.1% |
| Missing | 36 |
| Missing (%) | 0.6% |
| Memory size | 45.3 KiB |
| Minimum | 2018-05-25 00:00:00 |
|---|---|
| Maximum | 2099-12-31 00:00:00 |
First Posted
Date
| Distinct | 438 |
|---|---|
| Distinct (%) | 7.6% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 45.3 KiB |
| Minimum | 2007-12-12 00:00:00 |
|---|---|
| Maximum | 2021-04-14 00:00:00 |
MISSING 
| Distinct | 33 |
|---|---|
| Distinct (%) | 91.7% |
| Missing | 5747 |
| Missing (%) | 99.4% |
| Memory size | 45.3 KiB |
| Minimum | 2019-04-08 00:00:00 |
|---|---|
| Maximum | 2021-04-14 00:00:00 |
| Distinct | 269 |
|---|---|
| Distinct (%) | 4.7% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 45.3 KiB |
| Minimum | 2020-02-05 00:00:00 |
|---|---|
| Maximum | 2021-04-14 00:00:00 |
Locations
Text
MISSING 
| Distinct | 4255 |
|---|---|
| Distinct (%) | 81.9% |
| Missing | 585 |
| Missing (%) | 10.1% |
| Memory size | 45.3 KiB |
Length
| Max length | 63843 |
|---|---|
| Median length | 5419 |
| Mean length | 295.16006 |
| Min length | 18 |
Characters and Unicode
| Total characters | 1534242 |
|---|---|
| Distinct characters | 184 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 3765 ? |
|---|---|
| Unique (%) | 72.4% |
Sample
| 1st row | Groupe Hospitalier Paris Saint-Joseph, Paris, Ile De France, France |
|---|---|
| 2nd row | Cimedical, Barranquilla, Atlantico, Colombia |
| 3rd row | Ospedale Papa Giovanni XXIII, Bergamo, Italy|Policlinico San Marco-San Donato group, Bergamo, Italy|Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy|ASST di Lecco Ospedale Alessandro Manzoni, Lecco, Italy|ASST Melegnano-Martesana, Ospedale Santa Maria delle Stelle, Melzo, Italy|ASST Monza, Monza, Italy|AUSL Romagna-Ospedale Infermi di Rimini, Rimini, Italy|Istituto per la Sicurezza Sociale-Ospedale della Repubblica di San Marino, San Marino, San Marino |
| 4th row | Hong Kong Sanatorium & Hospital, Hong Kong, Hong Kong |
| 5th row | CHR Orléans, Orléans, France |
| Value | Count | Frequency (%) |
| united | 9742 | 5.5% |
| hospital | 5463 | 3.1% |
| of | 3963 | 2.2% |
| de | 3096 | 1.7% |
| university | 3032 | 1.7% |
| center | 2819 | 1.6% |
| medical | 2685 | 1.5% |
| 2492 | 1.4% | |
| site | 2443 | 1.4% |
| research | 1880 | 1.1% |
| Other values (19748) | 140645 |
Most occurring characters
| Value | Count | Frequency (%) |
| 173062 | 11.3% | |
| e | 127332 | 8.3% |
| a | 122277 | 8.0% |
| i | 111275 | 7.3% |
| t | 95674 | 6.2% |
| n | 92954 | 6.1% |
| o | 71878 | 4.7% |
| r | 68651 | 4.5% |
| s | 66169 | 4.3% |
| , | 65193 | 4.2% |
| Other values (174) | 539777 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 1534242 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| 173062 | 11.3% | |
| e | 127332 | 8.3% |
| a | 122277 | 8.0% |
| i | 111275 | 7.3% |
| t | 95674 | 6.2% |
| n | 92954 | 6.1% |
| o | 71878 | 4.7% |
| r | 68651 | 4.5% |
| s | 66169 | 4.3% |
| , | 65193 | 4.2% |
| Other values (174) | 539777 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 1534242 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| 173062 | 11.3% | |
| e | 127332 | 8.3% |
| a | 122277 | 8.0% |
| i | 111275 | 7.3% |
| t | 95674 | 6.2% |
| n | 92954 | 6.1% |
| o | 71878 | 4.7% |
| r | 68651 | 4.5% |
| s | 66169 | 4.3% |
| , | 65193 | 4.2% |
| Other values (174) | 539777 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 1534242 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| 173062 | 11.3% | |
| e | 127332 | 8.3% |
| a | 122277 | 8.0% |
| i | 111275 | 7.3% |
| t | 95674 | 6.2% |
| n | 92954 | 6.1% |
| o | 71878 | 4.7% |
| r | 68651 | 4.5% |
| s | 66169 | 4.3% |
| , | 65193 | 4.2% |
| Other values (174) | 539777 |
Study Documents
Text
MISSING 
| Distinct | 182 |
|---|---|
| Distinct (%) | 100.0% |
| Missing | 5601 |
| Missing (%) | 96.9% |
| Memory size | 45.3 KiB |
Length
| Max length | 489 |
|---|---|
| Median length | 381 |
| Mean length | 143.82967 |
| Min length | 85 |
Characters and Unicode
| Total characters | 26177 |
|---|---|
| Distinct characters | 64 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 182 ? |
|---|---|
| Unique (%) | 100.0% |
Sample
| 1st row | "Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/85/NCT04407585/SAP_000.pdf |
|---|---|
| 2nd row | "Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/44/NCT04674644/Prot_SAP_000.pdf |
| 3rd row | "Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/18/NCT04816318/SAP_000.pdf|"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/18/NCT04816318/Prot_001.pdf |
| 4th row | "Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/96/NCT04474496/Prot_SAP_000.pdf |
| 5th row | "Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/63/NCT04713163/Prot_SAP_000.pdf |
| Value | Count | Frequency (%) |
| protocol | 147 | |
| study | 131 | |
| analysis | 124 | |
| plan | 123 | |
| statistical | 104 | 8.3% |
| and | 98 | 7.8% |
| consent | 91 | 7.2% |
| form | 89 | 7.1% |
| informed | 58 | 4.6% |
| part | 4 | 0.3% |
| Other values (278) | 289 |
Most occurring characters
| Value | Count | Frequency (%) |
| o | 1626 | 6.2% |
| / | 1506 | 5.8% |
| t | 1426 | 5.4% |
| i | 1402 | 5.4% |
| l | 1278 | 4.9% |
| s | 1222 | 4.7% |
| a | 1121 | 4.3% |
| d | 1095 | 4.2% |
| 0 | 1085 | 4.1% |
| 1076 | 4.1% | |
| Other values (54) | 13340 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 26177 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| o | 1626 | 6.2% |
| / | 1506 | 5.8% |
| t | 1426 | 5.4% |
| i | 1402 | 5.4% |
| l | 1278 | 4.9% |
| s | 1222 | 4.7% |
| a | 1121 | 4.3% |
| d | 1095 | 4.2% |
| 0 | 1085 | 4.1% |
| 1076 | 4.1% | |
| Other values (54) | 13340 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 26177 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| o | 1626 | 6.2% |
| / | 1506 | 5.8% |
| t | 1426 | 5.4% |
| i | 1402 | 5.4% |
| l | 1278 | 4.9% |
| s | 1222 | 4.7% |
| a | 1121 | 4.3% |
| d | 1095 | 4.2% |
| 0 | 1085 | 4.1% |
| 1076 | 4.1% | |
| Other values (54) | 13340 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 26177 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| o | 1626 | 6.2% |
| / | 1506 | 5.8% |
| t | 1426 | 5.4% |
| i | 1402 | 5.4% |
| l | 1278 | 4.9% |
| s | 1222 | 4.7% |
| a | 1121 | 4.3% |
| d | 1095 | 4.2% |
| 0 | 1085 | 4.1% |
| 1076 | 4.1% | |
| Other values (54) | 13340 |
URL
Text
UNIQUE 
| Distinct | 5783 |
|---|---|
| Distinct (%) | 100.0% |
| Missing | 0 |
| Missing (%) | 0.0% |
| Memory size | 45.3 KiB |
Length
| Max length | 43 |
|---|---|
| Median length | 43 |
| Mean length | 43 |
| Min length | 43 |
Characters and Unicode
| Total characters | 248669 |
|---|---|
| Distinct characters | 30 |
| Distinct categories | 1 ? |
| Distinct scripts | 1 ? |
| Distinct blocks | 1 ? |
Unique
| Unique | 5783 ? |
|---|---|
| Unique (%) | 100.0% |
Sample
| 1st row | https://ClinicalTrials.gov/show/NCT04785898 |
|---|---|
| 2nd row | https://ClinicalTrials.gov/show/NCT04595136 |
| 3rd row | https://ClinicalTrials.gov/show/NCT04395482 |
| 4th row | https://ClinicalTrials.gov/show/NCT04416061 |
| 5th row | https://ClinicalTrials.gov/show/NCT04395924 |
| Value | Count | Frequency (%) |
| https://clinicaltrials.gov/show/nct04785898 | 1 | < 0.1% |
| https://clinicaltrials.gov/show/nct04473170 | 1 | < 0.1% |
| https://clinicaltrials.gov/show/nct04416061 | 1 | < 0.1% |
| https://clinicaltrials.gov/show/nct04395924 | 1 | < 0.1% |
| https://clinicaltrials.gov/show/nct04516954 | 1 | < 0.1% |
| https://clinicaltrials.gov/show/nct04476940 | 1 | < 0.1% |
| https://clinicaltrials.gov/show/nct04634214 | 1 | < 0.1% |
| https://clinicaltrials.gov/show/nct04602884 | 1 | < 0.1% |
| https://clinicaltrials.gov/show/nct04384588 | 1 | < 0.1% |
| https://clinicaltrials.gov/show/nct04355897 | 1 | < 0.1% |
| Other values (5773) | 5773 |
Most occurring characters
| Value | Count | Frequency (%) |
| / | 23132 | 9.3% |
| s | 17349 | 7.0% |
| l | 17349 | 7.0% |
| i | 17349 | 7.0% |
| h | 11566 | 4.7% |
| t | 11566 | 4.7% |
| C | 11566 | 4.7% |
| a | 11566 | 4.7% |
| T | 11566 | 4.7% |
| o | 11566 | 4.7% |
| Other values (20) | 104094 |
Most occurring categories
| Value | Count | Frequency (%) |
| (unknown) | 248669 |
Most frequent character per category
(unknown)
| Value | Count | Frequency (%) |
| / | 23132 | 9.3% |
| s | 17349 | 7.0% |
| l | 17349 | 7.0% |
| i | 17349 | 7.0% |
| h | 11566 | 4.7% |
| t | 11566 | 4.7% |
| C | 11566 | 4.7% |
| a | 11566 | 4.7% |
| T | 11566 | 4.7% |
| o | 11566 | 4.7% |
| Other values (20) | 104094 |
Most occurring scripts
| Value | Count | Frequency (%) |
| (unknown) | 248669 |
Most frequent character per script
(unknown)
| Value | Count | Frequency (%) |
| / | 23132 | 9.3% |
| s | 17349 | 7.0% |
| l | 17349 | 7.0% |
| i | 17349 | 7.0% |
| h | 11566 | 4.7% |
| t | 11566 | 4.7% |
| C | 11566 | 4.7% |
| a | 11566 | 4.7% |
| T | 11566 | 4.7% |
| o | 11566 | 4.7% |
| Other values (20) | 104094 |
Most occurring blocks
| Value | Count | Frequency (%) |
| (unknown) | 248669 |
Most frequent character per block
(unknown)
| Value | Count | Frequency (%) |
| / | 23132 | 9.3% |
| s | 17349 | 7.0% |
| l | 17349 | 7.0% |
| i | 17349 | 7.0% |
| h | 11566 | 4.7% |
| t | 11566 | 4.7% |
| C | 11566 | 4.7% |
| a | 11566 | 4.7% |
| T | 11566 | 4.7% |
| o | 11566 | 4.7% |
| Other values (20) | 104094 |
| Enrollment | Funded Bys | Gender | Phases | Rank | Status | Study Results | Study Type | |
|---|---|---|---|---|---|---|---|---|
| Enrollment | 1.000 | 0.000 | 0.000 | 0.000 | -0.112 | 0.000 | 0.000 | 0.030 |
| Funded Bys | 0.000 | 1.000 | 0.056 | 0.155 | 0.060 | 0.046 | 0.062 | 0.099 |
| Gender | 0.000 | 0.056 | 1.000 | 0.126 | 0.078 | 0.014 | 0.066 | 0.000 |
| Phases | 0.000 | 0.155 | 0.126 | 1.000 | 0.142 | 0.075 | 0.060 | 1.000 |
| Rank | -0.112 | 0.060 | 0.078 | 0.142 | 1.000 | 0.040 | 0.000 | 0.059 |
| Status | 0.000 | 0.046 | 0.014 | 0.075 | 0.040 | 1.000 | 0.158 | 0.419 |
| Study Results | 0.000 | 0.062 | 0.066 | 0.060 | 0.000 | 0.158 | 1.000 | 0.018 |
| Study Type | 0.030 | 0.099 | 0.000 | 1.000 | 0.059 | 0.419 | 0.018 | 1.000 |
| Rank | NCT Number | Title | Acronym | Status | Study Results | Conditions | Interventions | Outcome Measures | Sponsor/Collaborators | Gender | Age | Phases | Enrollment | Funded Bys | Study Type | Study Designs | Other IDs | Start Date | Primary Completion Date | Completion Date | First Posted | Results First Posted | Last Update Posted | Locations | Study Documents | URL | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | NCT04785898 | Diagnostic Performance of the ID Now™ COVID-19 Screening Test Versus Simplexa™ COVID-19 Direct Assay | COVID-IDNow | Active, not recruiting | No Results Available | Covid19 | Diagnostic Test: ID Now™ COVID-19 Screening Test | Evaluate the diagnostic performance of the ID Now ™ COVID-19 test carried out by nurses in an emergency department in comparison with the reference PCR test: Simplexa ™ COVID-19 Direct | Groupe Hospitalier Paris Saint Joseph | All | 18 Years and older  (Adult, Older Adult) | Not Applicable | 1000.0 | Other | Interventional | Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic | COVID-IDNow | November 9, 2020 | December 22, 2020 | April 30, 2021 | March 8, 2021 | NaN | March 8, 2021 | Groupe Hospitalier Paris Saint-Joseph, Paris, Ile De France, France | NaN | https://ClinicalTrials.gov/show/NCT04785898 |
| 1 | 2 | NCT04595136 | Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient | COVID-19 | Not yet recruiting | No Results Available | SARS-CoV-2 Infection | Drug: Drug COVID19-0001-USR|Drug: normal saline | Change on viral load results from baseline after using COVID19-0001-USR via nebulization | United Medical Specialties | All | 18 Years and older  (Adult, Older Adult) | Phase 1|Phase 2 | 60.0 | Other | Interventional | Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment | COVID19-0001-USR | November 2, 2020 | December 15, 2020 | January 29, 2021 | October 20, 2020 | NaN | October 20, 2020 | Cimedical, Barranquilla, Atlantico, Colombia | NaN | https://ClinicalTrials.gov/show/NCT04595136 |
| 2 | 3 | NCT04395482 | Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury | TAC-COVID19 | Recruiting | No Results Available | covid19 | Other: Lung CT scan analysis in COVID-19 patients | A qualitative analysis of parenchymal lung damage induced by COVID-19|A quantitative analysis of parenchymal lung damage induced by COVID-19|The potential impact of parenchymal morphological CT scans in patients with severe moderate respiratory failure.|Automated segmentation of lung scans of patients with COVID-19 and ARDS.|Knowledge of chest CT features in COVID-19 patients and their detail through the use of machine learning and other quantitative techniques.|The ability within which the analysis of artificial intelligence that uses deep learning models can be used to predict clinical outcomes | University of Milano Bicocca | All | 18 Years and older  (Adult, Older Adult) | NaN | 500.0 | Other | Observational | Observational Model: Cohort|Time Perspective: Retrospective | TAC-COVID19 | May 7, 2020 | June 15, 2021 | June 15, 2021 | May 20, 2020 | NaN | November 9, 2020 | Ospedale Papa Giovanni XXIII, Bergamo, Italy|Policlinico San Marco-San Donato group, Bergamo, Italy|Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy|ASST di Lecco Ospedale Alessandro Manzoni, Lecco, Italy|ASST Melegnano-Martesana, Ospedale Santa Maria delle Stelle, Melzo, Italy|ASST Monza, Monza, Italy|AUSL Romagna-Ospedale Infermi di Rimini, Rimini, Italy|Istituto per la Sicurezza Sociale-Ospedale della Repubblica di San Marino, San Marino, San Marino | NaN | https://ClinicalTrials.gov/show/NCT04395482 |
| 3 | 4 | NCT04416061 | The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic | COVID-19 | Active, not recruiting | No Results Available | COVID | Diagnostic Test: COVID 19 Diagnostic Test | Proportion of asymptomatic subjects|Proportion of subjects with recent contact history|Proportion of subjects with recent travel history | Hong Kong Sanatorium & Hospital | All | Child, Adult, Older Adult | NaN | 2500.0 | Industry | Observational | Observational Model: Cohort|Time Perspective: Retrospective | RC-2020-08 | May 25, 2020 | July 31, 2020 | August 31, 2020 | June 4, 2020 | NaN | June 4, 2020 | Hong Kong Sanatorium & Hospital, Hong Kong, Hong Kong | NaN | https://ClinicalTrials.gov/show/NCT04416061 |
| 4 | 5 | NCT04395924 | Maternal-foetal Transmission of SARS-Cov-2 | TMF-COVID-19 | Recruiting | No Results Available | Maternal Fetal Infection Transmission|COVID-19|SARS-CoV 2 | Diagnostic Test: Diagnosis of SARS-Cov2 by RT-PCR and : IgG, Ig M serologies in the amniotoc fluid, the blood cord and the placenta | COVID-19 by positive PCR in cord blood and / or positive serologies|COVID-19 by positive PCR in amniotic fluid and placenta|New born infected by COVID-19 | Centre Hospitalier Régional d'Orléans|Centre de Biophysique Moléculaire - Pr Chantal Pichon|Professeur TOUMI Hechmi | Female | 18 Years to 48 Years  (Adult) | NaN | 50.0 | Other | Observational | Observational Model: Cohort|Time Perspective: Prospective | CHRO-2020-10 | May 5, 2020 | May 2021 | May 2021 | May 20, 2020 | NaN | June 4, 2020 | CHR Orléans, Orléans, France | NaN | https://ClinicalTrials.gov/show/NCT04395924 |
| 5 | 6 | NCT04516954 | Convalescent Plasma for COVID-19 Patients | CPCP | Enrolling by invitation | No Results Available | COVID 19 | Biological: Convalescent COVID 19 Plasma | Evaluate the safety|Change in requirement for mechanical ventilatory support | Vinmec Research Institute of Stem Cell and Gene Technology|National Institute of Hygiene and Epidemiology, Vietnam|National Hospital for Tropical Diseases, Hanoi, Vietnam|National Institute of Hematology and Blood Transfusion, Vietnam | All | 18 Years to 75 Years  (Adult, Older Adult) | Early Phase 1 | 10.0 | Other | Interventional | Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment | ISC.20.11.1 | August 1, 2020 | November 30, 2020 | December 30, 2020 | August 18, 2020 | NaN | August 20, 2020 | Vinmec Research Institute of Stem cell and Gene Technology, Hanoi, Vietnam | NaN | https://ClinicalTrials.gov/show/NCT04516954 |
| 6 | 7 | NCT04476940 | COVID-19 Breastfeeding Guideline for African-Americans | COVID-BF | Not yet recruiting | No Results Available | Covid19|Exclusive Breastfeeding | Behavioral: COVID-19 Breastfeeding Support | COVID-19 breastfeeding guidance adherence at birth.|COVID-19 breastfeeding guidance adherence at 1-month postpartum.|COVID-19 breastfeeding guidance adherence at 3-months postpartum.|Exclusive breastfeeding at birth.|Exclusive breastfeeding at 1-month.|Exclusive breastfeeding at 3-months.|COVID_Status|COVID-19 Immunoglobulin G|COVID-19 Immunoglobulin M | Meharry Medical College | Female | 18 Years to 45 Years  (Adult) | Not Applicable | 200.0 | Other | Interventional | Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention | 330875 | September 2020 | October 2021 | June 2022 | July 20, 2020 | NaN | July 20, 2020 | Meharry Medical College, Nashville, Tennessee, United States | NaN | https://ClinicalTrials.gov/show/NCT04476940 |
| 7 | 8 | NCT04634214 | The Severity of COVID 19 in Diabetes and Non-diabetes Patients | COVID19 | Not yet recruiting | No Results Available | Covid19|Type2 Diabetes | NaN | Severity of COVID 19 among people with and without diabetes|Number of patients who were in ICU|Number of patients who had tracheal intubation|Number of patients who had respiratory complication|Number of death|Correlation of BMI with complications, tracheal intubation and mortality|Length of hospital stay | India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals | All | 18 Years to 99 Years  (Adult, Older Adult) | NaN | 1050.0 | Other | Observational | Observational Model: Case-Control|Time Perspective: Retrospective | IDRFARH015 | November 16, 2020 | February 16, 2021 | May 16, 2021 | November 18, 2020 | NaN | November 18, 2020 | Orthomed Hospital, Chennai, Tamil Nadu, India|Medway Hospital, Chennai, Tamil Nadu, India|Venkateswara Hospital, Chennai, Tamil Nadu, India|Dr. Rela Institute & Medical Center, Chennai, Tamil Nadu, India | NaN | https://ClinicalTrials.gov/show/NCT04634214 |
| 8 | 9 | NCT04602884 | Early Detection of COVID-19 Using Breath Analysis | COVID-19 | Suspended | No Results Available | Covid19 | Diagnostic Test: Breath biopsy sampling using the ReCIVA Breath Sampler | Correlation between Volatile Organic Compounds pattern and COVID-19 detection status.|Correlation between Volatile Organic Compounds pattern and time from COVID-19 detection.|Correlation between the set of Volatile Organic Compounds found in breath biopsy and disease intensity. | Scentech Medical Technologies Ltd | All | 18 Years to 55 Years  (Adult) | Not Applicable | 50.0 | Industry | Interventional | Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic | Cov-2-IDF | September 22, 2020 | December 30, 2021 | December 30, 2021 | October 26, 2020 | NaN | April 13, 2021 | IDF COVID 19 Isolation Facility, Ashkelon, Israel | NaN | https://ClinicalTrials.gov/show/NCT04602884 |
| 9 | 10 | NCT04384588 | COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID) | FALP-COVID | Recruiting | No Results Available | COVID-19 Infection|Cancer Patients|General Population | Biological: Convalescent Plasma from COVID-19 donors | in-hospital mortality secondary to COVID-19 among patients treated with convalescent plasma|safety of the use of convalescent plasma drom COVID 19 donors|Mortality at 30 days, 90 days, 6 months and 1 year|in-hospital Mortality COVID-19 related compared with non-treated population according to Chilean official reports|Number of days of hospitalization in high complexity facilities after convalescent plasma use|Number of days of hospitalization in intensive care unit after convalescent plasma use|Number of days of mechanical ventilatory support in patients after convalescent plasma use|Total number of days of mechanical ventilatory support|Total number of hospitalization days in patients treated with convalescent plasma|Number of hospitalization days in patients after treatment with convalescent plasma|Viral load measuring|Immunological response in treated patients (COVID19-Immunoglobulin M and Immunoglobulin G, neutralizing antibodies)|Negativization of COVID 19 load since convalescent plasma use|Negativization of COVID 19 load since hospitalization|Negativization of COVID 19 load since first reported symptoms COVID-19 related|Donor Interferon Gamma profile characterization|Donor Granulocyte Macrophage Colony Stimulating Factor characterization|Donor Tumor Necrosis Factor Alfa characterization|Donor Interleukin -1 beta characterization|Donor Interleukin-2 characterization|Donor Interleukin-4 characterization|Donor Interleukin-6 characterization|Donor Interleukin-8 characterization|Donor Interleukin-10 characterization|Receptor Interferon Gamma profile characterization|Receptor Granulocyte Macrophage Colony Stimulating Factor characterization|receptor Tumor Necrosis Factor Alfa characterization|receptor Interleukin -1 beta characterization|Receptor Interleukin-2 characterization|Receptor Interleukin-4 characterization|Receptor Interleukin-6 characterization|Receptor Interleukin-8 characterization|Receptor Interleukin-10 characterization | Fundacion Arturo Lopez Perez|Confederación de la Producción y del Comercio (CPC)|Bolsa de Santiago | All | 15 Years and older  (Child, Adult, Older Adult) | Phase 2|Phase 3 | 100.0 | Other | Interventional | Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment | FALP 001-2020 | April 7, 2020 | April 6, 2021 | April 6, 2021 | May 12, 2020 | NaN | May 12, 2020 | Fundacion Arturo Lopez Perez, Providencia, Santiago, Chile | NaN | https://ClinicalTrials.gov/show/NCT04384588 |
| Rank | NCT Number | Title | Acronym | Status | Study Results | Conditions | Interventions | Outcome Measures | Sponsor/Collaborators | Gender | Age | Phases | Enrollment | Funded Bys | Study Type | Study Designs | Other IDs | Start Date | Primary Completion Date | Completion Date | First Posted | Results First Posted | Last Update Posted | Locations | Study Documents | URL | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5773 | 5774 | NCT04639661 | Predictors of Periodontal Outcomes Post-sanative Therapy | NaN | Enrolling by invitation | No Results Available | Periodontal Diseases|Periodontal Pocket | NaN | Probing depth|Bleeding on probing|Tooth Loss|O'Leary Index of Plaque Control | Brock University|Dr. Peter C. Fritz, Periodontal Wellness & Implant Surgery | All | 19 Years and older  (Adult, Older Adult) | NaN | 200.0 | Other | Observational | Observational Model: Cohort|Time Perspective: Retrospective | 20-070 | November 25, 2020 | August 2021 | December 2021 | November 20, 2020 | NaN | December 4, 2020 | Dr. Peter C. Fritz, Periodontal Wellness & Implant Surgery, Fonthill, Ontario, Canada|Brock University, St. Catharines, Ontario, Canada | NaN | https://ClinicalTrials.gov/show/NCT04639661 |
| 5774 | 5775 | NCT04180709 | CBT to Reduce Insomnia and Improve Social Recovery in Early Psychosis | CRISP | Recruiting | No Results Available | Psychotic Disorders|Psychosis|Sleep | Device: Sleepio | Change from baseline Work and Social Adjustment Scale (WSAS) score at week 9 of study|Time Use Survey - Structured Hours (TUS-SH)|Patient Health Questionnaire (PHQ-9)|Rapid Visual Information Processing (RVP) / CANTAB Cognitive Test|Paired Associates Learning (PAL) / CANTAB Cognitive Test|Spatial Working Memory (SWM) / CANTAB Cognitive Test|Emotion Recognition Task (ERT) / CANTAB Cognitive Test|Global Assessment of Functioning (GAF) (split version / subscales GAF-D & GAF-S)|Change from baseline Work and Social Adjustment Scale (WSAS) score at week 17|Change from baseline Work and Social Adjustment Scale (WSAS) score at week 5, to correct for confounding in mediation analysis|Change from baseline Work and Social Adjustment Scale (WSAS) score at week 13, to correct for confounding in mediation analysis | University of Cambridge|Cambridgeshire and Peterborough NHS Foundation Trust|Cambridge Cognition Ltd|Big Health | All | 18 Years and older  (Adult, Older Adult) | Not Applicable | 44.0 | Other|Industry | Interventional | Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care | M00915|RNAG-521|224101|19/EE/0352 | October 30, 2020 | November 30, 2022 | November 30, 2022 | November 27, 2019 | NaN | November 3, 2020 | Cameo Early Intervention, Cambridge, Cambridgeshire, United Kingdom | NaN | https://ClinicalTrials.gov/show/NCT04180709 |
| 5775 | 5776 | NCT04335643 | Telehealth CBT for Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus | cSLE | Recruiting | No Results Available | Systemic Lupus Erythematosus | Behavioral: TEACH | Recruitment rates of the study|Retention rates of the study|Feasibility of remotely-delivered TEACH|Changes in fatigue, as measured by the PROMIS Fatigue SF|Long-term changes in fatigue, as measured by the PROMIS Fatigue SF|Changes in depressive symptoms, as measured by the CDI-2 and BDI-II|Long-term changes in depressive symptoms, as measured by the CDI-2 and BDI-II | Michigan State University|Arthritis Foundation|The Hospital for Sick Children | All | 12 Years to 22 Years  (Child, Adult) | Not Applicable | 75.0 | Other | Interventional | Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment | STUDY00003882 | August 4, 2020 | December 2021 | December 2021 | April 6, 2020 | NaN | March 9, 2021 | Michigan State University, Grand Rapids, Michigan, United States|The Hospital for Sick Children, Toronto, Ontario, Canada | NaN | https://ClinicalTrials.gov/show/NCT04335643 |
| 5776 | 5777 | NCT04589377 | Mindfulness to Mitigate Psychological Threat and Improve Engagement and Learning in Introductory Physics Courses | NaN | Recruiting | No Results Available | Stress | Behavioral: Mindfulness Training | Mean differences in Psychological Threat measured via Ecological Momentary Assessment|Mean differences in Physics Motivation assessed via Ecological Momentary Assessment|Mean change in Psychological Threat measured via Self-Report|Mean change in Physics Interest measured via Self-Report|Mean change in Physics Self-Efficacy measured via Self-Report|Mean change in Physics Value measured via Self-Report|Mean change in Physics Identity measured via Self-Report|Mean change in Physics Belonging measured via Self-Report|Mean change in Physics Achievement Goals measured via Self-Report|Mean change in Physics Growth Mindset measured via Self-Report|Mean differences in Meaning Making and Positive Reappraisal assessed via Ecological Momentary Assessment|Mean differences in Affect assessed via Ecological Momentary Assessment|Mean differences in Mindfulness assessed via Ecological Momentary Assessment|Mean differences in Equanimity assessed via Ecological Momentary Assessment|Mean change in Meaning Making and Positive Reappraisal assessed via Self-Report|Mean change in Physics Engagement assessed via Self-Report|Mean change in Physics Anxiety assessed via Self-Report|Mean change in Physics performance on the assessment|Mean differences in Performance on the Preparation for Future Learning Task|Mean change of judgments of confidence, anxiety, and difficulty during physics assessment via Self-Report | University of Pittsburgh|U.S. National Science Foundation|James S McDonnell Foundation | All | 18 Years and older  (Adult, Older Adult) | Not Applicable | 150.0 | Other|U.S. Fed | Interventional | Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment | STUDY19050258 | October 26, 2020 | August 31, 2022 | December 31, 2022 | October 19, 2020 | NaN | November 10, 2020 | University of Pittsburgh, Pittsburgh, Pennsylvania, United States | NaN | https://ClinicalTrials.gov/show/NCT04589377 |
| 5777 | 5778 | NCT04574466 | Scaling-up Psychological Interventions With Syrian Refugees in Switzerland (STRENGTHS_CH): RCT | NaN | Recruiting | No Results Available | Distress|PTSD|Anxiety|Depression|Trauma|Functional Disabilities|Common Mental Health Problems | Behavioral: Problem Management Plus | Change in psychological distress|Change in posttraumatic stress disorder symptoms|Change in functional disability | University of Zurich | All | 18 Years and older  (Adult, Older Adult) | Not Applicable | 380.0 | Other | Interventional | Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment | BASEC-2017-01175-rct | August 25, 2020 | June 2022 | June 2022 | October 5, 2020 | NaN | October 5, 2020 | Klinik für Konsiliarpsychiatrie und Psychosomatik, Zürich, Switzerland | NaN | https://ClinicalTrials.gov/show/NCT04574466 |
| 5778 | 5779 | NCT04011644 | Mobile Health for Alcohol Use Disorders in Clinical Practice | NaN | Recruiting | No Results Available | Alcohol Drinking|Telemedicine | Behavioral: A-CHESS self-monitored|Behavioral: A-CHESS peer-supported|Behavioral: A-CHESS clinically-integrated | Number of risky drinking days|Number of patients who are willing to share data|Number of healthcare services used in the past 6 months|Cost of implementation of each intervention arm in US dollars|Number of patient risk factors assessed by a revised Brief Alcohol Monitor|Number of days health coach/other clinician used the A-CHESS dashboard|Score of Alcohol Use Disorders Identification Test (AUDIT) screening tool|Score of the Diagnostic and Statistical Manual- 5 Alcohol use disorder (AUD) severity|Score of relatedness as assessed by the CHESS Bonding Scale|Score of competence as assessed by the Perceived competence scale (PCS)|Score of autonomous motivation as assessed by revised Treatment Self Regulation Questionnaire|Time of A-CHESS used|Number of setback status triggered by A-CHESS|Variables used for predictive setback status|Number of response statuses addressed|Score of overall quality of life as assessed by Patient Reported Outcomes Measurement Information System (PROMIS) Global-10|Pages viewed on A-CHESS|Number of patient protection factors assessed by a revised Brief Alcohol Monitor | University of Wisconsin, Madison|National Institute on Alcohol Abuse and Alcoholism (NIAAA) | All | 21 Years to 100 Years  (Adult, Older Adult) | Not Applicable | 566.0 | Other|NIH | Interventional | Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment | 2019-0337|R01AA024150|A532007|SMPH/FAMILY MED/RES GRANTS|Protocol Version 1/26/2021 | March 23, 2020 | August 2022 | April 2023 | July 8, 2019 | NaN | April 2, 2021 | UW Health at the American Center, Madison, Wisconsin, United States | NaN | https://ClinicalTrials.gov/show/NCT04011644 |
| 5779 | 5780 | NCT04681339 | Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia | NaN | Not yet recruiting | No Results Available | Community Acquired Pneumonia in Children|Antibiotic Stewardship | Other: Antibiotic treatment|Other: No antibiotic treatment | Antibiotic treatment rates in hospitalized children with non-severe community-acquired pneumonia and fever|Number of medical complications|Factors in physician decision making on antibiotic prescription|Parental satisfaction|Hospitalization duration|Number of children with relevant comorbidity|Days of supplemental oxygen use|Use of antipyretic medications|Number of complementary medicine medications used per child|Number of readmissions for pneumonia or new pneumonia recurrences within 4 weeks of hospital discharge | ARCIM Institute Academic Research in Complementary and Integrative Medicine|Gemeinschaftskrankenhaus Herdecke, Germany | All | 3 Months to 18 Years  (Child, Adult) | NaN | 200.0 | Other | Observational | Observational Model: Cohort|Time Perspective: Prospective | PKA-03 | April 2021 | November 2024 | December 2024 | December 23, 2020 | NaN | February 10, 2021 | Die Filderklinik, Filderstadt, Baden-Württemberg, Germany|Herdecke Community Hospital, Herdecke, Nordrhein-Westfalen, Germany | NaN | https://ClinicalTrials.gov/show/NCT04681339 |
| 5780 | 5781 | NCT04740229 | Moderate-intensity Flow-based Yoga Effects on Cognition and Stress | NaN | Recruiting | No Results Available | Stress|Psychological | Behavioral: Yoga | Perceived Stress|Task switching paradigm|Digit span forward and backward|Digit symbol substitution test (DSST)|Stroop task | University of Illinois at Urbana-Champaign | All | 18 Years to 64 Years  (Adult) | Not Applicable | 88.0 | Other | Interventional | Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment | 21584 | February 10, 2021 | July 2021 | July 2021 | February 5, 2021 | NaN | February 24, 2021 | University of Illinois at Urbana-Champaign, Urbana, Illinois, United States | NaN | https://ClinicalTrials.gov/show/NCT04740229 |
| 5781 | 5782 | NCT04804917 | 3-year Follow-up of the Mind My Mind RCT | MindMyMindFU | Recruiting | No Results Available | Emotional Problem|Anxiety Disorder of Childhood|Depressive Symptoms|Behavior Problem of Childhood and Adolescence|Mental Health Disorder | NaN | The child's impact of mental health problems reported by the parent on the Strengths and Difficulties Questionnaire Impact Scale.|Emotional and behavioral problems|School attendance: proportion of school-days within the last 4 weeks, where the child is present (no illegal absence)|Child Health Utility instrument (CHU9D)|The Parental Stress Scale (PSS) | Mental Health Services in the Capital Region, Denmark|Frederiksberg University Hospital|Defactum, Central Denmark Region|The Danish Mental Health Foundation | All | 8 Years to 20 Years  (Child, Adult) | NaN | 396.0 | Other | Observational | Observational Model: Other|Time Perspective: Prospective | MHSCRDenmark, F-61502-03-1 | March 22, 2021 | May 31, 2022 | December 31, 2022 | March 18, 2021 | NaN | April 1, 2021 | Mental Health Services in the Capital Region, Denmark, Copenhagen, Denmark | NaN | https://ClinicalTrials.gov/show/NCT04804917 |
| 5782 | 5783 | NCT04680000 | Chronic Pain Management In Primary Care Using Behavioral Health Consultants | NaN | Not yet recruiting | No Results Available | Chronic Pain | Behavioral: Brief Cognitive Behavioral Therapy for Chronic Pain (BCBT-CP)|Other: BCBT-CP Booster | Defense and Veterans Pain Rating Scale (DVPRS)|Behavioral Health Measure-20 (BHM-20)|Pain Intensity, Enjoyment and General Activity (PEG-3)|Modified Oswestry Disability Index (ODI)|Pain Catastrophizing Scale (PCS)|Chronic Pain Acceptance Questionnaire (CPAQ)|Insomnia Severity Index (ISI)|Two-Item Patient Health Questionnaire (PHQ-2) | The University of Texas Health Science Center at San Antonio|Uniformed Services University of the Health Sciences|Massachusetts General Hospital|Defense Health Agency|59th Medical Wing|Brooke Army Medical Center|C.R.Darnall Army Medical Center | All | 18 Years and older  (Adult, Older Adult) | Not Applicable | 716.0 | Other|U.S. Fed | Interventional | Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment | HSC20200520H | February 2021 | February 2024 | February 2025 | December 22, 2020 | NaN | December 22, 2020 | Uniformed Services University for the Health Sciences, Bethesda, Maryland, United States|University of Texas Health Science Center San Antonio, San Antonio, Texas, United States | NaN | https://ClinicalTrials.gov/show/NCT04680000 |